about
A prolonged severe intoxication after ingestion of phenytoin and phenobarbital.Total Phenytoin concentration is not well correlated with active free drug in critically-ill head trauma patients.The importance of drug interactions in epilepsy therapy.Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability.Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjectsCo-regulation of phenytoin and tolbutamide metabolism in humans.Pharmacokinetics of phenytoin in children.Plasma protein binding of phenytoin in 100 epileptic patients.Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.Protein binding and CSF penetration of phenytoin following acute oral dosing in man.Rapid anticonvulsant monitoring in an epilepsy clinic.Population pharmacokinetics of phenytoin from routine clinical data in Japan.Clinical toxicology.Bioavailability and dissolution of proprietary and generic formulations of phenytoinTherapeutic drug monitoring of phenytoin in critically ill patients.Clinically relevant anti-epileptic drug interactions.Phenytoin removal by continuous venovenous hemofiltration.Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.Dose-dependent pharmacokinetics: emphasis on phase I metabolism.Phenytoin disposition and toxicity: role of pharmacogenetic and interethnic factors.Pharmacokinetic investigation of the interaction of azapropazone with phenytoin.Variations in the Blood Phenytoin Levels during Long-Term Combined Treatment with S-1 and Phenytoin.The effect of tenidap sodium on the disposition and plasma protein binding of phenytoin in healthy male volunteersEffect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy.Comparison of the effectiveness of two oral phenytoin products and chronopharmacokinetics of phenytoin.Serum protein binding kinetics of phenytoin in monotherapy patients.The assessment of bioavailability in the presence of nonlinear elimination.
P2860
Q28367023-E2305763-D5EC-40FF-B137-27B9CBA5C3E2Q33828046-E3992B50-2D1F-4308-A91C-6EE930301E9DQ34123652-EE2A3DE5-5EDD-44BC-9666-E6C5395A15E9Q34345819-9D4D5663-55ED-4AC0-8876-C8514F515A6AQ34398477-90878B12-CB2E-46E4-88A3-FDD25A76CDC7Q34403326-9F70329B-6C60-4B76-BF7D-F9448DA6986CQ34449678-38B29BF0-3A79-476C-AEE7-BBF30A2D97ECQ34512209-E3040B33-FA7F-46C9-A48F-7E3B5C4F49FEQ34596313-B934BAFC-883B-4FED-8502-8236005E245BQ34622211-81CF5169-8EC1-4A8E-9EEB-A2CD9B99133BQ35625069-9FB0376D-7EBF-4BFA-A1D4-0930B22972ADQ36417519-7A2B238B-A827-4093-A033-94AC0F778F80Q36683160-6A8E56D4-72C3-4A1F-BD64-B5830C49DEA7Q36966092-CDE91A28-055C-42D0-92C3-5DB79A033A20Q37310486-0EAB5205-5855-4D42-B919-2E50812E9640Q37920931-1348205E-564D-4C4B-B919-C39DED704E8AQ38164694-3FAAD9E3-7C5E-4B31-889E-94BE3C90C291Q38181565-8A41AD87-778B-49BB-AB8E-504557928140Q38513684-A69523B0-B363-44B7-9931-0DA4480E52A9Q40153504-16592E51-D073-4EED-B158-0245A0A04F91Q40923025-ADD7F260-4F43-4B97-ADB7-2EC8391BA9E3Q41907962-356FB34F-8F54-48EF-813A-CF308C68FC38Q42088181-B1E6C6EF-11F2-4D11-AA3D-756C66C9116AQ42141493-5C9BE35F-A181-45F6-B021-02FAA6C45805Q43651099-AB0C3B31-D37C-450E-8BC4-81C06114C95AQ46304182-C9615A8D-88CD-488A-9F78-B075039929C8Q52228230-CFC38232-0753-492B-BEC4-EE1A2714DFF2Q52564191-F327EFB0-6662-4683-8AB6-F53AADD21F0B
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Clinical pharmacokinetics of phenytoin.
@en
Clinical pharmacokinetics of phenytoin.
@nl
type
label
Clinical pharmacokinetics of phenytoin.
@en
Clinical pharmacokinetics of phenytoin.
@nl
prefLabel
Clinical pharmacokinetics of phenytoin.
@en
Clinical pharmacokinetics of phenytoin.
@nl
P1476
Clinical pharmacokinetics of phenytoin.
@en
P2093
P304
P356
10.2165/00003088-197904030-00001
P577
1979-05-01T00:00:00Z
P6179
1009567244